Why is Sharda Cropchem Ltd falling/rising?

Recent Price Movement and Market Performance

Sharda Cropchem Ltd closed at ₹840.85, down ₹17.10 or 1.99% as of 08:44 PM on 29 December. This marks the third consecutive day of decline, with the stock losing 5.81% over this period. The intraday low touched ₹836.40, reflecting a 2.51% drop from the previous close. The weighted average price indicates that a greater volume of shares traded closer to the day’s low, signalling selling pressure among investors. Compared to its sector, the stock underperformed by 1.71% on the day.

Examining the stock’s recent returns against the benchmark Sensex reveals a mixed picture. Over the past week, Sharda Cropchem’s shares have fallen 5.50%, significantly underperforming the Sensex’s modest 1.02% decline. Over one month, the stock’s loss of 2.43% slightly exceeds the Sensex’s 1.18% fall. However, on a year-to-date basis, the stock has gained 6.10%, though this lags the Sensex’s 8.39% rise. Over one year, the company’s shares have appreciated 7.73%, marginally outperforming the Sensex’s 7.62%. Longer-term returns remain impressive, with three-year gains of 67.60% and five-year returns exceeding 200%, well above the benchmark’s respective 38.54% and 77.88%.

Technical Indicators and Investor Participation

From a technical standpoint, the stock is trading above its 200-day moving average, a positive long-term signal. However, it remains below its 5-day, 20-day, 50-day, and 100-day moving averages, indicating short- to medium-term weakness. This technical setup suggests that while the long-term trend remains intact, recent momentum has faltered.

Investor participation appears to be waning, with delivery volumes falling 16.2% compared to the five-day average, down to 54,240 shares on 26 December. This decline in delivery volume may reflect reduced conviction among buyers, contributing to the recent price softness. Despite this, liquidity remains adequate, with the stock’s traded value supporting transactions of up to ₹0.2 crore without significant market impact.

Strong Fundamentals Underpinning the Stock

Despite the recent price weakness, Sharda Cropchem’s underlying business fundamentals remain robust. The company boasts a zero average debt-to-equity ratio, indicating a clean balance sheet with no reliance on debt financing. Profit before tax excluding other income for the latest quarter stood at ₹56.35 crore, reflecting an impressive growth rate of 181.19%. Net sales for the latest six months reached ₹1,913.92 crore, up 22.53%, signalling healthy top-line expansion.

Return on capital employed (ROCE) for the half-year period is notably high at 20.59%, while return on equity (ROE) stands at 16.9%. These metrics highlight efficient capital utilisation and strong profitability. The stock’s price-to-book value ratio of 2.8 suggests an attractive valuation relative to its peers and historical averages. Furthermore, the company’s profits have surged by 107.5% over the past year, outpacing the stock’s 7.73% price appreciation, resulting in a low PEG ratio of 0.2. This indicates that the stock may be undervalued relative to its earnings growth potential.

Promoters remain the majority shareholders, providing stability and confidence in the company’s strategic direction. Additionally, Sharda Cropchem is ranked among the top 1% of companies rated by MarketsMojo across a universe of 4,000 stocks, underscoring its strong market standing and investment appeal.

Conclusion: Short-Term Pressure Amid Long-Term Strength

The recent decline in Sharda Cropchem’s share price appears to be driven primarily by short-term technical factors and reduced investor participation rather than any deterioration in the company’s fundamentals. While the stock has underperformed the benchmark and its sector over the past week and month, its long-term performance remains strong, with substantial gains over three and five years. The company’s impressive profit growth, strong returns on capital, and conservative capital structure provide a solid foundation for future appreciation.

Investors should weigh the current price weakness against the company’s attractive valuation and robust financial health. The dip may offer a buying opportunity for those focused on long-term value in the pesticides and agrochemicals sector, especially given the stock’s favourable PEG ratio and high-quality ratings.

Get 2 full years of MojoOne Premium for only Rs. 12,999. Subscribe for 1 year and we'll add another year FREE. Offer valid for a limited time. Start Saving Now →